Phenomune, LLC
Phenotypic biomarker discovery platform for wellness and disease prediction
- Sector
- Biotech
- Headquarters
- THE WOODLANDS, TX
- Founded
- 2021
- Latest Form D
- $3.3M, Aug 2021
- Total capital
- $3.3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3.3M
- 1 Form D · last Aug 2021
- 62 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 15 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$3.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Chambliss Anton HarrodDirectorNamed in SEC Form D filings
- Helena Elizabeth SpeekExecutive OfficerNamed in SEC Form D filings
- Henry Anton BarhamDirectorNamed in SEC Form D filings
- Robert Anton GerhardExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 15- PendingCompositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Cannabis Tasting Preferences, Characterization Of Cannabis In Relation To Individual Tasting Preferences, And Selection Of CannabisUSPTOApplication 18454598
- PendingCompositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Wine Tasting Preferences, Characterization Of Wine In Relation To Individual Tasting Preferences, And Selection Of WineUSPTOApplication 18513534
- PendingCompositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Distilled Spirit Tasting Preferences, Characterization Of Distilled Spirit In Relation To Individual Tasting Preferences, And Selection Of Distilled SpiritUSPTOApplication 18506015
Show all 15 patent records
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Cannabis Tasting Preferences, Characterization Of Cannabis In Relation To Individual Tasting Preferences, And Selection Of CannabisDec 12, 2024 · Application 18454598Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Wine Tasting Preferences, Characterization Of Wine In Relation To Individual Tasting Preferences, And Selection Of WineOct 17, 2024 · Application 18513534Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Distilled Spirit Tasting Preferences, Characterization Of Distilled Spirit In Relation To Individual Tasting Preferences, And Selection Of Distilled SpiritJul 4, 2024 · Application 18506015Pending
- Testing Methods For Determination Of T2R Phenotype And Applications ThereofJun 23, 2022 · Application 17693928Pending
- Testing Methods for Determination of T2R Phenotype and Applications ThereofApr 21, 2022 · Application 17500755Pending
- Characterization Of Phenotypic Expression Of Bitter Taste Receptors For The Gut Microbiome And Applications ThereofApplication 63356739Pending
- Compositions, Systems, And Methods For Treatment With T2R Agonists From Terpenes, Plant Material, Cannabis Plant Material, And Hemp Plant MaterialApplication 63353571Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Wine Tasting Preferences, Characterization Of Wine In Relation To Individual Tasting Preferences, And Selection Of WineApplication 63350397Pending
- Compositions, Systems, And Methods For Treatment With T2R Agonist Nasal Sprays And Applications ThereofApplication 63340630Pending
- Testing Methods For Determination Of T2R Phenotype And Applications ThereofApplication PCTUS2022024892Pending
- Testing Methods For Determination Of T2R Phenotype And Applications ThereofApplication PCTUS2021054810Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Wine Tasting Preferences, Characterization Of Wine In Relation To Individual Tasting Preferences, And Selection Of WineApplication 63384363Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Distilled Spirit Tasting Preferences, Characterization Of Distilled Spirit In Relation To Individual Tasting Preferences, And Selection Of Distilled SpiritApplication 63382970Pending
- Compositions, Systems, And Methods For Determination Of T2R And/or T1R Phenotype In Individuals To Predict Cannabis Tasting Preferences, Characterization Of Cannabis In Relation To Individual Tasting Preferences, And Selection Of CannabisApplication 63400215Pending
- Compositions, Systems, And Methods For Predicting Genotype From Phenotypic Expression Of T2RS And Test Methods ThereofApplication 63391246Pending
Related companies, and why
- Aliada TherapeuticsSimilar federal contract value in Biotech · null in contracts
- OptiNose, Inc.Similar federal contract value in Biotech · null in contracts
- Telo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Manifold Technologies Ltd.Similar federal contract value in Biotech · null in contracts
- Virax Biolabs Group LtdSimilar federal contract value in Biotech · null in contracts
- MingSight Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .